Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
University of Washington Department of Laboratory Medicine, |
RCV000210157 | SCV000266205 | uncertain significance | Lynch syndrome | 2015-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000215593 | SCV000275333 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-10-02 | criteria provided, single submitter | clinical testing | The p.A737V variant (also known as c.2210C>T), located in coding exon 4 of the MSH6 gene, results from a C to T substitution at nucleotide position 2210. The alanine at codon 737 is replaced by valine, an amino acid with similar properties. This variant was identified in an individual whose colorectal tumor demonstrated normal mismatch repair protein expression by immunohistochemistry (IHC) (Shirts BH et al. Genet Med, 2016 Oct;18:974-81). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Color Diagnostics, |
RCV000215593 | SCV000908395 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-10-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001044010 | SCV001207782 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-08-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000210157 | SCV004836251 | uncertain significance | Lynch syndrome | 2024-05-09 | criteria provided, single submitter | clinical testing |